Adam,Rouilly was delighted to provide male pelvis and genital organ models to Prospect to use at awareness-raising events across the area and in group sessions for men with prostate cancer. The SOOMSO MO17 Median Section of the Male Pelvis, and MO15 Model of the Male Genital Organs effectively demonstrate where the prostate is and its […]
Public health messaging around PCa places a misleading focus on urinary symptoms and may be hampering efforts of early detection, scientists have warned. Researchers said there was “no evidence of a causal link between PCa and either prostate size or troublesome urinary symptoms”. But public health guidance regularly promotes this link. Worried about PCa? Check […]
Scientists have early evidence that one way to kill recurring cancer cells may be with a lot of iron. More here
Scientists discover a new molecule that kills even the deadliest cancer, but no mention of PCa. See more here
People with a worrying cough, problems swallowing or blood in their urine will soon be able to be referred for scans and checks by a pharmacist, rather than by their GP. A new pilot scheme, in England, aims to diagnose more cancers early, when there is a better chance of a cure. The NHS also […]
Drinking milk has links to PCa, it’s alleged. More here. But better news about a cancer killer here
Scientists say they have identified urine bacteria which are linked to aggressive PCa. The discovery might provide new ways to spot and even prevent these dangerous tumours, experts hope. See more And scientists have hypothesised that if they found a way to get zinc into malignant cells that might be helpful. More here
A research team has discovered specific changes in a protein that drive the growth and spread of PCa. See more here
A new PinPoint blood test being tested could rule out cancer for 500,000 people a year, with the results back from the NHS within just two or three days (Mar ’22). More here
A breakthrough triple therapy for advanced PCa can give patients years more healthy life and reduces the overall risk of death by a third. The regime involves two standard therapies alongside a powerful new hormone medication, darolutamide (Mar ’22). More here